Professional Documents
Culture Documents
AC
CE
PT
ED
1
2
3
Received: January 9, 2009 / Revised: February 26, 2009 / Accepted: March 12, 2009
Ding et al.
NFPF
NFEF
NFMF
NFHF
Comp. 1
Comp. 2
Comp. 3
Comp. 4
5-Fua
IC50 (g/ml)
13.80
>100
>30.00
>30.00
0.28
0.31
1.54
0.16
0.03
AC
CE
PT
ED
Dose
(mg/kg/day)
Control
NFPF
NFEF
NFMF
NFHF
Comp. 1
Comp. 2
Comp. 3
5-Fua
500
100
500
100
500
100
500
100
100
50
100
50
100
50
25
Tumor weight
(g)
0.400.18
0.120.07*
0.330.12
0.290. 25
0.350.16
0.150.08*
0.250.20
0.500.17
0.560.12
0.350.15
0.170.07*
0.280.09
0.140.06*
0.240.14
0.360.18
0.100.04**
a
5-Fu was used as the positive control.
*p<0.05, **p<0.01 compared with control group.
Inhibition rate
(%)
69.4
16.2
26.6
13.4
61.8
38.5
12.7
57.4
29.5
63.8
39.1
10.8
74.8
REFERENCES
AC
CE
PT
ED
Fig. 1. Thymus index (A) and spleen index (B) of H22 mice
treated with each sample from N. fasciculare (n=10).
The control group was administered with saline; the positive group was
administered with 5-Fu (25 mg/kg/day); sample groups were administered
with each fraction (500 and 100 mg/kg/day) and each compound (100 and
50 mg/kg/day), respectively. *p<0.05, **p<0.01 compared with the
control group. +p<0.05, ++p<0.01 compared with the 5-Fu group.
Acknowledgments
Ding et al.
25.
26.
27.
AC
CE
PT
ED
28.
29.
30.
31.
32.